| 000 | 01383 a2200397 4500 | ||
|---|---|---|---|
| 005 | 20250517212302.0 | ||
| 264 | 0 | _c20190319 | |
| 008 | 201903s 0 0 eng d | ||
| 022 | _a1536-3686 | ||
| 024 | 7 |
_a10.1097/MJT.0000000000000741 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPandey, Nivedita | |
| 245 | 0 | 0 |
_aTacrolimus-Associated Jaundice. _h[electronic resource] |
| 260 |
_bAmerican journal of therapeutics _c |
||
| 300 |
_ae723-e725 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Letter | ||
| 650 | 0 | 4 |
_aAllografts _xdrug effects |
| 650 | 0 | 4 | _aBiopsy |
| 650 | 0 | 4 |
_aChemical and Drug Induced Liver Injury _xcomplications |
| 650 | 0 | 4 |
_aGraft Rejection _ximmunology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunosuppressive Agents _xadverse effects |
| 650 | 0 | 4 |
_aJaundice _xdiagnosis |
| 650 | 0 | 4 |
_aLiver _xdrug effects |
| 650 | 0 | 4 |
_aLiver Cirrhosis _xetiology |
| 650 | 0 | 4 | _aLiver Function Tests |
| 650 | 0 | 4 |
_aLiver Transplantation _xadverse effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNon-alcoholic Fatty Liver Disease _xcomplications |
| 650 | 0 | 4 |
_aTacrolimus _xadverse effects |
| 700 | 1 | _aGupta, Anjali K | |
| 700 | 1 | _aGupta, Subash | |
| 773 | 0 |
_tAmerican journal of therapeutics _gvol. 25 _gno. 6 _gp. e723-e725 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/MJT.0000000000000741 _zAvailable from publisher's website |
| 999 |
_c28303970 _d28303970 |
||